Alyeska Investment Group, L.P. Werewolf Therapeutics, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 235,705 shares of HOWL stock, worth $384,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235,705
Previous 235,705
-0.0%
Holding current value
$384,199
Previous $228,000
12.28%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HOWL
# of Institutions
66Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA6.68MShares$10.9 Million0.16% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$7.03 Million10.84% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$3.93 Million0.51% of portfolio
-
Bank Of America Corp Charlotte, NC2.13MShares$3.47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$2.59 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $48.1M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...